Acute myocardial infarction and drug-eluting stents
Prediction of first coronary events with the Framingham score
Bringing cardiovascular cell-based therapy to clinical application
The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) Trial study design
Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction
Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty
Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome
Early invasive versus conservative treatment in patients with failed fibrinolysis—no late survival benefit
Outcome after prenatal diagnosis of tricuspid atresia
Atrial septostomy improves survival in select patients with pulmonary hypertension
Do race-specific models explain disparities in treatments after acute myocardial infarction?
Outcome after out-of-hospital cardiac arrest in a physician-staffed emergency medical system according to the Utstein style
Detection of pulmonary vein stenosis by transesophageal echocardiography
Polytetrafluoroethylene graft calcification in patients with surgically repaired congenital heart disease
Relationship and prognostic value of coronary artery calcification by electron beam computed tomography to stress-induced ischemia by single photon emission computed tomography
Prospective assessment after pediatric cardiac ablation
Effect of the G-308A polymorphism of the tumor necrosis factor α gene on the risk of ischemic heart disease and ischemic stroke
Long-term survival after successful inhospital cardiac arrest resuscitation
Corrections
Absence of bilateral vision loss from amiodarone
Improvement in diastolic function and left ventricular filling pressure induced by cardiac resynchronization therapy
Detection of viral genome in the myocardium
Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure
A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure
Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease
Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study
AMPD1 gene polymorphism and survival in patients with stable congestive heart failure
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure. A study on 686 consecutive patients
Letter to the editor by Dr. Duminda N. Wijeysundera
Letter to the editor by Dr. Duminda N. Wijeysundera
Allogeneic blood transfusions and infections after cardiac surgery
Allogeneic blood transfusions and infections after cardiac surgery
Letter of comment on “Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial” (Am Heart J 2006;152:887.e9–14)
Letter of comment on “Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial” (Am Heart J 2006;152:887.e9–14)
Debate on DEBATE
Response to Letter to the Editor by Dr Martin Fortin